PsyLabs
PrivateLast Round
Series A
Aug 15, 2025
Est. Valuation
$10M
Total Funding Raised
$9.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PsyLabs is a biotechnology company that specializes in the cultivation, extraction, and production of pharmaceutical-grade psychedelic active pharmaceutical ingredients (APIs) for medical and clinical research markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PsyLabs Comparables
Compare PsyLabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Natural MedTech | 89% | |
| Psygen Industries Ltd. | 83% | |
| Eywa Biotech | 81% | |
PsyLabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 15, 2025 | ||||
| Strategic | Apr 15, 2025 | ||||
| Seed | Dec 3, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 25% QoQ, from 12 to 15 employees.
PsyLabs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PsyLabs's valuation, stock price, and market status.